嗜铬细胞瘤/副神经节瘤患者病史中糖代谢紊乱的长期持续存在
该回顾性多中心队列分析纳入188例现患或既往嗜铬细胞瘤/副神经节瘤(PPGL)患者、27例转移性PPGL患者及44例无症状致病性变异携带者,比较术后至少12个月随访的113例既往PPGL患者与76例无功能肾上腺腺瘤对照。既往PPGL患者高血糖性疾病患病率及平均HbA1c均显著高于对照,提示PPGL切除后糖代谢紊乱长期持续。
要点
- 既往PPGL患者高血糖性疾病患病率显著高于无症状致病性变异携带者(P=.013)。
- 术后至少12个月随访的既往PPGL患者高血糖性疾病患病率显著高于无功能肾上腺腺瘤对照(P<.001)。
- 既往PPGL患者平均HbA1c 5.63%(SD 0.43%)显著高于对照的5.45%(SD 0.40%)(P=.004)。
核心结论
- PPGL切除后糖代谢紊乱长期持续存在。
研究设计与样本
- 回顾性分析多中心队列,纳入参与前瞻性ProsPheo研究和ENS@T登记处的PPGL患者,比较既往PPGL患者与ENS@T登记处无功能肾上腺腺瘤对照。
- 纳入现患或既往PPGL患者188例、转移性PPGL患者27例、已知PPGL易感基因致病性变异但无PPGL病史的无症状携带者44例。
- 在诊断时和随访期间评估糖代谢状态、血脂异常和体质指数(BMI)等心血管代谢危险因素。
主要发现
- 既往PPGL患者高血糖性疾病患病率显著高于无症状致病性变异携带者(P=.013)。
- 术后至少12个月随访的既往PPGL患者(n=113)高血糖性疾病患病率显著高于年龄和BMI相似的无功能肾上腺腺瘤对照(n=76)(P<.001)。
- 既往PPGL患者平均HbA1c为5.63%(SD 0.43%),显著高于对照组的5.45%(SD 0.40%)(P=.004)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Pheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors that frequently produce catecholamines. Catecholamine-induced cardiometabolic complications substantially contribute to increased morbidity and mortality in PPGL patients prior to surgical resection. OBJECTIVE: To determine whether markers of elevated cardiometabolic risk persist in patients following PPGL resection. METHODS: In this retrospective analysis of a multicenter cohort of patients with PPGLs participating in the prospective ProsPheo study and the ENS@T registry, cardiometabolic risk factors, including glycemic status, dyslipidemia, and body mass index (BMI), were assessed in patients with PPGL at diagnosis and during follow-up. Patients with a history of resected PPGL were compared to a control group with nonfunctioning adrenal adenomas from the ENS@T registry. RESULTS: Patients with a present PPGL or a history of PPGL (n = 188), a metastatic PPGL (n = 27), or a known susceptibility gene pathogenic variant (PV) for the development of PPGL without a history of PPGL (n = 44) were included. We compared the asymptomatic PV carriers to patients with a history of PPGL: those with a history of PPGL showed a significantly higher prevalence of hyperglycemic disorders (P = .013) compared with asymptomatic PV carriers. In patients with a history of PPGL and at least 12 months of follow-up post surgery (n = 113), the prevalence of hyperglycemic disorders (P < .001), as well as the mean HbA1c (5.63%, SD 0.43%), were significantly higher, compared to a control group with nonfunctioning adrenal adenomas (n = 76) of similar age and BMI (HbA1c 5.45%, SD 0.40%; P = .004). CONCLUSION: Glycemic disturbances persist long-term after the resection of PPGL.
引用
- Fischer A, Remde H, Pamporaki C, et al. Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma. J Clin Endocrinol Metab. 2025. PMID: 39745823. doi:10.1210/clinem/dgae901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。